{"id":"hidroferol","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypercalcemia"},{"rate":null,"effect":"Hyperphosphatemia"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL3544909","moleculeType":"Small molecule","molecularWeight":"418.66"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Hidroferol (calcifediol) is a synthetic vitamin D metabolite that binds to vitamin D receptors in target tissues, promoting calcium absorption in the intestine and regulating bone mineralization. It is used to correct vitamin D deficiency and manage disorders of calcium and phosphate metabolism, particularly in patients with chronic kidney disease or hypoparathyroidism.","oneSentence":"Hidroferol is a vitamin D analog that activates vitamin D receptors to regulate calcium and phosphate metabolism and modulate immune function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:47:35.211Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Vitamin D deficiency"},{"name":"Hypocalcemia in chronic kidney disease"},{"name":"Hypoparathyroidism"},{"name":"Osteomalacia"}]},"trialDetails":[{"nctId":"NCT07479303","phase":"","title":"Vitamin D Status in Young Medical Residents","status":"COMPLETED","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2025-10-29","conditions":"Vitamin D Deficiency","enrollment":30},{"nctId":"NCT05543928","phase":"PHASE3","title":"Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism","status":"TERMINATED","sponsor":"OPKO Health, Inc.","startDate":"2023-01-31","conditions":"Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Vitamin d Deficiency","enrollment":2},{"nctId":"NCT05460234","phase":"","title":"RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2022-10-05","conditions":"Chronic Kidney Disease","enrollment":110},{"nctId":"NCT06258850","phase":"PHASE4","title":"REstoration of VItamin D in Pulmonary Arterial Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2024-07-01","conditions":"Pulmonary Artery Hypertension, Vitamin d Deficiency","enrollment":102},{"nctId":"NCT05803681","phase":"NA","title":"CCEF in the Treatment of Acute VFFs: Randomized Controlled Trial","status":"COMPLETED","sponsor":"University of Bari Aldo Moro","startDate":"2015-01-01","conditions":"Vertebral Fracture, Osteoporotic Fractures","enrollment":70},{"nctId":"NCT02805907","phase":"PHASE4","title":"Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)","status":"COMPLETED","sponsor":"MurciaSalud","startDate":"2016-06","conditions":"Asthma, Bronchial","enrollment":112},{"nctId":"NCT01017354","phase":"PHASE2","title":"Zurich Disability Prevention Trial","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2010-01","conditions":"Community-dwelling Seniors, History of a Fall in the Previous 12 Months","enrollment":200},{"nctId":"NCT01596842","phase":"PHASE4","title":"Effect of Omega-3 Fatty Acid on Vitamin D Activation","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2012-05","conditions":"Hemodialysis Patients, Vitamin D Insufficiency, Vitamin D Deficiency","enrollment":17},{"nctId":"NCT00752401","phase":"PHASE3","title":"Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2009-05","conditions":"Kidney Transplantation, Vitamin D Deficiency, Renal Osteodystrophy","enrollment":200},{"nctId":"NCT01442272","phase":"PHASE4","title":"Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D","status":"UNKNOWN","sponsor":"Hospital Universitario de Canarias","startDate":"2012-01","conditions":"Kidney Failure, Chronic, Disorder of Vitamin D","enrollment":174}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["B"],"phase":"marketed","status":"active","brandName":"Hidroferol®","genericName":"Hidroferol®","companyName":"Hospital Universitario de Canarias","companyId":"hospital-universitario-de-canarias","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hidroferol is a vitamin D analog that activates vitamin D receptors to regulate calcium and phosphate metabolism and modulate immune function. Used for Vitamin D deficiency, Hypocalcemia in chronic kidney disease, Hypoparathyroidism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}